Chronic graft-versus-host disease

Search with Google Search with Bing
Information
Disease name
Chronic graft-versus-host disease
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT01366092 Active, not recruiting Phase 2 Daily IL-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease July 2011 December 2024
NCT02759731 Active, not recruiting Phase 1/Phase 2 Study of Baricitinib, a JAK1/2 Inhibitor, in Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation November 1, 2016 May 30, 2024
NCT02966301 Completed Phase 2 Treatment of Chronic Graft Versus Host Disease With Arsenic Trioxide December 2016 June 2020
NCT01161628 Completed Phase 2 Rituximab for the Primary Treatment of Denovo Extensive Chronic Graft Versus Host Disease (GVHD) April 2011 July 2015
NCT01862965 Completed Phase 2 Treatment of Newly Diagnosed Moderate or Severe Chronic Graft-versus-host Disease With Prednisone and Everolimus March 6, 2013 March 2019
NCT01956903 Completed Phase 1/Phase 2 Treatment of Refractory Acute Graft-Versus-Host Disease by Sequential Infusion of Allogenic Mesenchymal Stem Cell. January 2010 September 2013
NCT02040623 Completed Phase 2 Safety and Efficacy Study of R932348 Ophthalmic Solution in Chronic Ocular Graft Versus Host Disease Patients(DROPS-2) March 2014 July 2016
NCT02411474 Completed Tear Cytokine Analysis as a Prediction or Diagnostic Marker in Ocular GvHD March 2014 August 2014
NCT02991846 Completed A Prospective Observational Study for Evaluating CGVHD September 1, 2017 November 22, 2022
NCT06458127 Not yet recruiting N/A Tele-Palliative Care Intervention for Patients With Chronic Graft-Versus-Host Disease July 1, 2024 March 31, 2026
NCT02918188 Recruiting Phase 2 Therapeutic Effects of Hydrogen on Steroid-refractory/or Steroid-dependent cGVHD January 2016 January 2031
NCT02611180 Recruiting Dendritic Cells in Patients With Acute or Chronic Skin Graft Versus Host Disease April 30, 2015 April 30, 2025
NCT05690971 Recruiting N/A Psychosocial Mobile App for Chronic Graft-Versus-Host Disease January 23, 2023 April 1, 2025
NCT02669251 Recruiting Phase 1/Phase 2 Alvelestat (MPH966), an Oral Neutrophil Elastase Inhibitor, in Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation April 28, 2016 December 1, 2024
NCT01903473 Terminated Phase 2 Donor Regulatory T Cells Infusion in Patients With Chronic Graft-versus-host Disease (GVHD) July 2013 September 12, 2022
NCT03584516 Terminated Phase 2/Phase 3 GRAVITAS-309: Itacitinib and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease January 17, 2019 November 3, 2023
NCT01226420 Terminated Phase 2 Alefacept in Subjects With Steroid-Refractory Chronic Graft-versus-Host Disease October 2010 August 2012
NCT01898377 Terminated Phase 2 Imatinib Mesylate and Mycophenolate Mofetil for Steroid-Refractory Sclerotic/Fibrotic cGVHD in Children August 2013 February 14, 2018
NCT02291770 Unknown status Phase 3 Treatment of Chronic Graft-Versus-Host Disease With Mesenchymal Stromal Cells October 2014 December 2019
NCT01158105 Unknown status Phase 2 Bortezomib for the Treatment of Refractory Chronic Graft-vs-Host Disease(cGVHD) June 2010 January 2017
NCT01765660 Unknown status Phase 2 Mesenchymal Stem Cells for Treatment of Refractory Chronic Graft-versus-host Disease January 2013 December 2016
NCT04692376 Unknown status Phase 2 MSC for Treatment of cGVHD After Allo-HSCT January 10, 2021 June 30, 2023
NCT01028313 Withdrawn Phase 2 A Study of Panobinostat (LBH589) as Second-Line Therapy in Patients With Chronic Graft-Versus-Host Disease